LG

Lauren Grizzard

Vice President Of Regulatory Affairs & Quality Assurance at Eyenovia

Lauren Grizzard has extensive work experience in the fields of regulatory affairs and quality assurance. Lauren is currently the Vice President of Regulatory Affairs & Quality Assurance at Eyenovia, Inc., a position they have held since November 2023. Prior to this, they served as the Associate Vice President of Regulatory Affairs & Quality Assurance from January to November 2023. Lauren also worked as the Director of Quality Assurance from July 2021 to November 2023, and as a Senior Quality Manager from January 2020 to July 2021. Before joining Eyenovia, they held positions at NuSil Technology LLC, where they worked as an Auditor - Supplier Quality / Quality Systems Administrator from 2014 to 2017. Lauren also served as a Quality System Supervisor from 2012 to 2014, a Quality System Specialist from 2011 to 2012, and a Manufacturing Administrative Assistant from 2009 to 2010. Lauren Grizzard started their career as an Intern at Kay and Associates, Inc. in 2006.

Lauren Grizzard earned a Bachelor of Science degree in Business with a minor in Economics from CA State University Channel Island in 2009. In 2016, they obtained a Certified Quality Auditor certification from ASQ, as well as a cGMP System Based Audits Certification from the Center for Professional Advancement. In 2015, Lauren received an ISO 13485 Internal Auditor Certificate from CLS Consulting Services, LLC. In 2014, they achieved a Certified Quality Improvement Associate certification from ASQ. Additionally, Lauren obtained a Lean Six Sigma Green Belt Certification from Purdue University in 2013. In 2009, they also earned a SHIRM Essentials of Human Resources Certificate from California State University Channel Islands Extended University.

Location

Camarillo, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Eyenovia

Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic company developing a pipeline of advanced therapeutics based on its proprietary microdose array print platform technology.


Industries

Employees

51-200

Links